These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19920797)

  • 1. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
    Van de Werf F; Ristić AD; Averkov OV; Arias-Mendoza A; Lambert Y; Kerr Saraiva JF; Sepulveda P; Rosell-Ortiz F; French JK; Musić LB; Vandenberghe K; Bogaerts K; Westerhout CM; Pagès A; Danays T; Bainey KR; Sinnaeve P; Goldstein P; Welsh RC; Armstrong PW;
    Circulation; 2023 Aug; 148(9):753-764. PubMed ID: 37439219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year follow-up data from the STEPP-AMI study: A prospective, observational, multicenter study comparing tenecteplase-facilitated PCI versus primary PCI in Indian patients with STEMI.
    Victor SM; Vijayakumar S; Alexander T; Bahuleyan CG; Srinivas A; Selvamani S; Priya SM; Kamaleswari K; Mullasari AS
    Indian Heart J; 2016; 68(2):169-73. PubMed ID: 27133326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic utility of GRACE risk score in predictive cardiovascular event rate in STEMI patients with successful fibrinolysis and delay intervention in non PCI-capable hospital: a retrospective cohort study.
    Chotechuang Y; Phrommintikul A; Muenpa R; Patumanond J; Chaichuen T; Kuanprasert S; Thanachikun N; Benjanuwatra T; Sukonthasarn A
    BMC Cardiovasc Disord; 2016 Nov; 16(1):212. PubMed ID: 27821064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport Times.
    van Diepen S; Zheng Y; Senaratne JM; Tyrrell BD; Das D; Thiele H; Henry TD; Bainey KR; Welsh RC
    Circ Cardiovasc Interv; 2024 Feb; 17(2):e013415. PubMed ID: 38293830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metrics of care and cardiovascular outcomes in patients with ST-elevation myocardial infarction treated with pharmacoinvasive strategy: a decade-long network in a populous city in Brazil.
    De Marqui Moraes PI; Galhardo A; Barbosa AHP; de Sousa JMA; Alves CMR; Bianco HT; Dos Santos Povoa RM; Stefanini E; Goncalves I; de Almeida DR; Fonseca FAH; de Oliveira Izar MC; Moises VA; Lopes RD; Carvalho AC; Caixeta A
    BMC Cardiovasc Disord; 2023 Jun; 23(1):300. PubMed ID: 37322425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paramedic Interventions and Adverse Patient Events during Prolonged Interfacility Ground Transport in a "Drip and Ship" Pharmacoinvasive Model of STEMI Care.
    Sibley AK; McQuaid W; Jain TN; Mills A; Travers A
    Prehosp Emerg Care; 2024; 28(2):375-380. PubMed ID: 36794866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaco-invasive Therapy: A Continued Role for Fibrinolysis in the Primary PCI era.
    Bouyaddid S; Bouchlarhem A; Bazid Z; Ismaili N; El Ouafi N
    Clin Appl Thromb Hemost; 2023; 29():10760296231221549. PubMed ID: 38145624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction.
    Helal AM; Shaheen SM; Elhammady WA; Ahmed MI; Abdel-Hakim AS; Allam LE
    Int J Cardiol Heart Vasc; 2018 Dec; 21():87-93. PubMed ID: 30402534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different reperfusion strategies on recovery of ventricular function after ST-segment elevation myocardial infarction: A longitudinal single-center study.
    Attar A; Namvar S; Hosseinpour A; Azami P; Shekari A; Jamali L; Goudarzi N
    Health Sci Rep; 2024 Jun; 7(6):e2220. PubMed ID: 38933425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Streptokinase in the Management of Myocardial Infarction in Developing Countries.
    Muoghalu CG; Ekong N; Wyns W; Ofoegbu CC; Newell M; Ebirim DA; Alex-Ojei ST
    Cureus; 2023 Aug; 15(8):e44125. PubMed ID: 37750155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute management of ST-segment-elevation myocardial infarction.
    Carville SF; Henderson R; Gray H
    Clin Med (Lond); 2015 Aug; 15(4):362-7. PubMed ID: 26407386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acute myocardial infarction in Peru and its relationship with in-hospital adverse events: results from the second peruvian registry of ST-segment elevation myocardial infarction (PERSTEMI-II).].
    Chacón-Diaz M; Rodríguez Olivares R; Miranda Noé D; Custodio-Sánchez P; Montesinos Cárdenas A; Yábar Galindo G; Rotta Rotta A; Isla Bazán R; Rojas de la Cuba P; Llerena Navarro N; López Rojas M; García Cárdenas M; Hernández Vásquez A
    Arch Peru Cardiol Cir Cardiovasc; 2021; 2(2):86-95. PubMed ID: 37727802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoinvasive Strategy in ST-elevation Myocardial Infarction: Particularities in the Elderly.
    Cesena F
    Arq Bras Cardiol; 2023 Jan; 120(1):e20220885. PubMed ID: 36790309
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
    Scheldeman L; Sinnaeve P; Albers GW; Lemmens R; Van de Werf F
    Eur Heart J; 2024 Jun; ():. PubMed ID: 38941344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Position statement for improvement in reperfusion of ST-elevation myocardial infarction in Latin America].
    Costabel JP; Quintana M; Perea J; Lamelas P; Candiello A; Sanhueza P; Arias-Mendoza A; Saavedra I; Rivera-Toquica A; de Castro ML; Álvarez-Gaviria M; Belardi J; Cequier Á; Sosa-Liprandi Á; Villarreal R
    Arch Cardiol Mex; 2024 Jan; 94(2):208-218. PubMed ID: 38227853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proposal for initial management of uncomplicated ST elevation myocardial infarction in centers without percutaneous coronary intervention capacity in Peru].
    Custodio-Sánchez P; Miranda-Noé D; López-Rojas LM; Paredes Paucar CP; Yábar Galindo WG; Rojas De La Cuba P; Martos Salcedo JO; Chacón-Diaz M
    Arch Peru Cardiol Cir Cardiovasc; 2023; 4(4):164-183. PubMed ID: 38298415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic description and outcomes of a metropolitan network for myocardial infarction treatment.
    Gopar-Nieto R; Araiza-Garaygordobil D; Raymundo-Martínez GI; Martínez-Amezcua P; Cabello-López A; Manzur-Sandoval D; Chávez-Gómez NL; Loáisiga-Sáenz AE; Baeza-Herrera LA; Dattoli-García CA; Gallardo-Grajeda LA; Jackson-Pedroza CN; Salas-Teles B; Arias-Mendoza A
    Arch Cardiol Mex; 2021 Jan; 91(2):167-177. PubMed ID: 33471783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Keeping an eye on the pharmacoinvasive strategy].
    Britto FW
    Arch Peru Cardiol Cir Cardiovasc; 2024; 5(1):59-60. PubMed ID: 38596608
    [No Abstract]   [Full Text] [Related]  

  • 19. Drip-and-ship for acute ST-segment myocardial infarction: the pharmacoinvasive strategy for patients treated with fibrinolytic therapy.
    Goodman SG; Cantor WJ
    Pol Arch Med Wewn; 2009 Nov; 119(11):726-30. PubMed ID: 19920797
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.